RU93005244A - DERIVATIVES OF QUINOLINE, PHARMACEUTICAL COMPOSITION - Google Patents

DERIVATIVES OF QUINOLINE, PHARMACEUTICAL COMPOSITION

Info

Publication number
RU93005244A
RU93005244A RU93005244/04A RU93005244A RU93005244A RU 93005244 A RU93005244 A RU 93005244A RU 93005244/04 A RU93005244/04 A RU 93005244/04A RU 93005244 A RU93005244 A RU 93005244A RU 93005244 A RU93005244 A RU 93005244A
Authority
RU
Russia
Prior art keywords
alkyl
hydrogen
optionally protected
halo
quinoline
Prior art date
Application number
RU93005244/04A
Other languages
Russian (ru)
Inventor
Джилмор Джереми
Тодд Алек
Original Assignee
Лилли Индастриз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лилли Индастриз Лимитед filed Critical Лилли Индастриз Лимитед
Publication of RU93005244A publication Critical patent/RU93005244A/en

Links

Claims (1)

Соединение формулы
Figure 00000001

в котором R1 - водород, гало, C1-4-алкил, C1-4-алкоксил, нитрил, возможно защищенная карбоксильная группа, возможно защищенный тетразолил, тригалоидметил, окси-C1=00-4-алкил, альдегин, -CH2Z, -CH=CH-Z или -CH2CH2Z , где Z - возможно защищенная карбоксильная группа или возможно защищенный тетразолил; R2 - гало, нитрил, возможно защищенная кислотная группа или -CONR7R8, где R7 и R8 - каждый водород или C1-4-алкил, R3 и R4 - каждый водород, C1-4-алкил, возможно замещенный фенил, или C1-4-алкил, замещенный группой -CONR7R8 или возможно защищенной кислотной группой;
Figure 00000002

Figure 00000003

Figure 00000004

где W - -CH= CH-, CH= N-, -N= CH-, -O- или -S-, R9 - водород, гало, C1-4-алкил, C1-4-алкоксил или тригалоидметил и R10 - водород, C1-4-алкил,
C2-6-алкенил, C3-6-циклоалкил или C1-4-алкил, C3-6-циклоалкил; R6 - водород или C1-4-алкил; X - -O-(CH2)nCR11CR12 или -CR11-Cr12, где R11, R12, R13 и R14 - каждый водород или C1-4-алкил, и n - 0, 1 или 2; Y - -O-CR15R16-, CR15=CR16 или Cr15R16 • CR17R18-, где R15, R16, R17 и R18 - каждый водород или C1-4-алкил; или их соль. Соединения в незащищенной форме являются активными лейкотриновыми антагонистами.
Compound of formula
Figure 00000001

wherein R 1 - hydrogen, halo, C 1 - 4 alkyl, C 1 - 4 -alkoxy, nitrile, optionally protected carboxyl group, optionally protected tetrazolyl, trihalomethyl, hydroxy-C 1 = 00- 4 -alkyl aldegin - CH 2 Z, —CH═CH — Z or —CH 2 CH 2 Z, where Z is optionally protected carboxyl group or optionally protected tetrazolyl; R 2 - halo, nitrile, an optionally protected acid group or -CONR 7 R 8 where R 7 and R 8 - are each hydrogen or C 1 - 4 alkyl, R 3 and R 4 - are each hydrogen, C 1 - 4 alkyl optionally substituted phenyl, or C 1 - 4 alkyl substituted by -CONR 7 R 8 or optionally protected acid group;
Figure 00000002

Figure 00000003

Figure 00000004

where W - -CH = CH-, CH = N-, -N = CH-, -O- or -S-, R 9 - H, halo, C 1 - 4 alkyl, C 1 - 4 -alkoxy or trihalomethyl and R 1 0 is hydrogen, C 1 - 4 alkyl,
C 2 - 6 -alkenyl, C 3 - 6 -cycloalkyl or C 1 - 4 alkyl, C 3 - 6 -cycloalkyl; R 6 - hydrogen or C 1 - 4 alkyl; X - -O- (CH 2 ) n CR 1 1 CR 1 2 or -CR 1 1 -Cr 1 2 , where R 1 1 , R 1 2 , R 1 3 and R 1 4 - each hydrogen or C 1 - 4 -alkyl, and n - 0, 1 or 2; Y - -O-CR 1 5 R 1 6 -, CR 1 5 = CR 1 6 or Cr 1 5 R 1 6 • CR 1 7 R 1 8 -, where R 1 5 , R 1 6 , R 1 7 and R 1 8 - each hydrogen or C 1 - 4 alkyl; or their salt. Unprotected compounds are active leukotrin receptor antagonists.
RU93005244/04A 1990-07-31 1993-06-07 DERIVATIVES OF QUINOLINE, PHARMACEUTICAL COMPOSITION RU93005244A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9107486.4 1991-04-09
GB9016790.9 1991-04-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU5001275 Division

Publications (1)

Publication Number Publication Date
RU93005244A true RU93005244A (en) 1996-05-10

Family

ID=

Similar Documents

Publication Publication Date Title
DE69925141D1 (en) CHINAZOLINE DERIVATIVES
KR910000735A (en) Fused 2, 3-dihydroxypyrazine and preparation method thereof
CA2376304A1 (en) Amide substituted imidazoquinolines
RU92004429A (en) DERIVATIVES 2- (1-PIPERASINIL) -4-PHENYL-CYCLO-ALKANOPYRIDINE
KR900016186A (en) 5-alkylquinolone carboxylic acid
RU98111511A (en) TRICYCLIC PYRAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION
RU95114449A (en) Derivatives of 4-aryl- or heteroaryl-6-amino-nicotinic acid, a mixture of their isomers or separate isomers, and also a pharmaceutical composition with a modulatory cali num ate ia i'm i'm i'm i'm i'm going
RU95115522A (en) CONNECTION SUITABLE FOR THE TREATMENT OF CNS DISEASES, PHARMACEUTICAL COMPOSITION
RU93056600A (en) PHENOXY- AND PHENOXIALKYLPIPERIDINE COMPOUNDS AND ANTI-VIRUS COMPOSITION
RU2002102551A (en) New derivatives of piperazinylalkylthiopyrimidine, pharmaceutical compositions containing them and a method for preparing the active substance
KR880000413A (en) Anti-allergic and anti-inflammatory preparations and preparation methods thereof
EP0387070A3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
KR940011450A (en) Fungicidal 2-alkoxy-2-imidazolin-5-one derivatives
RU93005244A (en) DERIVATIVES OF QUINOLINE, PHARMACEUTICAL COMPOSITION
KR930021638A (en) Imidazopyridine
ES2104370T3 (en) DERIVATIVES OF (ARYLALKYLAMINOBENCIL) SUBSTITUTED AMINOPROPIONAMIDES, THEIR PREPARATION AND USE.
KR910005871A (en) Cephalosporin Injection Preparations
ATE182138T1 (en) N-(2-(PYRROLIDINYL-1)-1-PHENYLETHYL>ACETAMIDE AS KAPPA RECEPTOR AGONISTS
ES520774A0 (en) PROCEDURE FOR THE PREPARATION OF THYOMETHYLPIRIDINE DERIVATIVES.
YU47839B (en) PROCEDURE FOR OBTAINING HINOLIN BENZIL INDOLA DERIVATIVES AND ITS DERIVATIVES
KR930021629A (en) Piperazine Derivatives
KR950032146A (en) Triazole compound and method for preparing same and use thereof
KR880005090A (en) 1.3-disubstituted imidazolium salts
ATE318800T1 (en) INDOLE DERIVATIVES AS MCP-1 RECEPTOR ANTAGONISTS
EP0127150A3 (en) 2,6-disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same